Literature DB >> 4107114

Complement sensitivity of neuraminidase-treated lymphoid cells.

P K Ray, H Gewurz, R L Simmons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4107114     DOI： 10.1097/00007890-197110000-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.

Authors:  P K Ray; K Sundaram
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  Antitumor immune response following injection of neuraminidase-treated sarcoma cells.

Authors:  R P Faraci; J A Marrone; A S Ketcham
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

3.  Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.

Authors:  P K Ray; R L Simmons
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

Review 4.  Membrane alterations in health and disease with particular reference to immune function and cancer.

Authors:  P K Ray; A K Prasad
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

5.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

6.  Y bodies and similar fluorescent chromocentres in human tumours including teratomata.

Authors:  N B Atkin
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

7.  Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells.

Authors:  K K Sethi; H Brandis
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.